Marken James G. 4
4 · ANI PHARMACEUTICALS INC · Filed Aug 25, 2023
Insider Transaction Report
Form 4
Marken James G.
Vice President, Operations
Transactions
- Exercise/Conversion
Common Stock
2023-08-23$40.59/sh+3,750$152,213→ 135,377 total - Exercise/Conversion
Stock Option (right to buy)
2023-08-23$40.59/sh−3,750$152,213→ 0 totalExercise: $40.59Exp: 2026-04-06→ Common Stock (3,750 underlying) - Exercise/Conversion
Stock Option (right to buy)
2023-08-23$33.00/sh−1,667$55,011→ 0 totalExercise: $33.00Exp: 2024-03-31→ Common Stock (1,667 underlying) - Exercise/Conversion
Common Stock
2023-08-23$33.00/sh+1,667$55,011→ 137,044 total - Sale
Common Stock
2023-08-23$63.00/sh−3,932$247,716→ 133,112 total
Footnotes (2)
- [F1]25% of the total options vested on each of April 7, 2017, April 7, 2018, April 7, 2019, and April 7, 2020.
- [F2]25% of the total options vested on each of April 1, 2015, April 1, 2016, April 1, 2017, and April 1, 2018.